When studying the mechanisms of protection, it was observed that adoptive transfer of CD11c+ cells (DCs) from siIDO treated mice into tumor bearing mice delayed tumor progression, and also that depletion of CD8 T cells abrogated tumor regression [72]. Here, ITGAX is linked to neoplasm.